The Trip Report
En podkast av Beckley Waves - Torsdager
Kategorier:
38 Episoder
-
Special Dispatch: An Election Retrospective with Nick Gillespie
Publisert: 13.11.2024 -
#35 Lucia Huang: Innovative Solutions in Neuropsychiatry
Publisert: 31.10.2024 -
#34 Shamil Chandaria: Computational Neuroscience and Human Flourishing
Publisert: 17.10.2024 -
#33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field
Publisert: 3.10.2024 -
#32 Rachelle Sampson & Bennet Zelner: The Connected Leadership Study
Publisert: 19.9.2024 -
Ep #31 Rebecca Kronman: Psychedelics & Parenting
Publisert: 5.9.2024 -
Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy
Publisert: 22.8.2024 -
Special Dispatch: FDA Rejects Lykos’ MDMA Assisted Therapy Application
Publisert: 13.8.2024 -
#29 Dr. Selma Holden MD: All Eyes on the FDA
Publisert: 8.8.2024 -
#28 East Forest: Music for Mushrooms
Publisert: 25.7.2024 -
#27 Joanna Kempner: Psychedelic Outlaws
Publisert: 11.7.2024 -
#26 Brandon Kapelow: ‘An Act of Service’- A Journey Through PTSD and Ketamine Therapy
Publisert: 27.6.2024 -
#25 Christof Koch: Exploring Consciousness and Perception
Publisert: 13.6.2024 -
#24 Manesh Girn Ph.D. - Exploring the Psychedelic Brain and Human Potential
Publisert: 30.5.2024 -
#23 Dennis Walker: The Court Jester of Psychedelics
Publisert: 16.5.2024 -
#22 Bruce Damer: Catalyzing Scientific and Creative Breakthroughs
Publisert: 2.5.2024 -
#21: Pedro Teixeira, Ph.D. - Psychedelics and Health Behavior Change
Publisert: 18.4.2024 -
#20: Jackie von Salm, Ph.D. - Natural Products & Novel Therapies
Publisert: 4.4.2024 -
#19 Beckley Academy: Charting the Course for Psychedelic-Assisted Therapy
Publisert: 21.3.2024 -
#18 Rick Doblin: The Path to MDMA Approval and Beyond
Publisert: 7.3.2024
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com
